“SAN ANTONIO – Data from the NRG (NSABP B-39/RTOG 0413) trial indicated that ipsilateral breast tumor recurrence (IBTR) rates...
SAN ANTONIO – Treatment with a low dose of tamoxifen (5 mg per day) halved the risk of disease...
“SAN ANTONIO – Patients with triple-negative breast cancer who delayed starting adjuvant chemotherapy for more than 30 days after...
“SAN ANTONIO – Pathological complete response (pCR) after neoadjuvant (presurgery) chemotherapy was associated with significantly lower recurrence risk and...
Adjuvant T-DM1 improved invasive disease-free survival (IDFS) in patients with HER2-positive early breast cancer with residual invasive disease at...
Subgroup analysis suggested the treatment may benefit patients with nonbasal-like disease SAN ANTONIO Treating patients who had early-stage triple-negative...
PHILADELPHIA – A program that provided individually tailored lifestyle recommendations for patients undergoing screening for colorectal cancer helped encourage...
On behalf of the Board of Directors of the American Association for Cancer Research (AACR), and the 40,000 laboratory...
“The Pancreatic Cancer Collective, the strategic partnership of the Lustgarten Foundation and Stand Up To Cancer (SU2C), has awarded...
PHILADELPHIA – Patients who are diagnosed with adenomas, a possible precursor of colorectal cancer, often do not receive subsequent...